RxDoctor Payments Data

Janelle Thomas, MD

Emergency Medicine · Marietta, OHNPI 1023040953

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 64.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $154 and has fallen 86.3% since, to $21 in 2025. Among emergency medicine clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$376in general payments, 2019–2025

Across 20 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$243
  • CSL Behring$48
  • Gilead$27
  • Octapharma USA, Inc.$24
  • AstraZeneca$20
  • Novartis$14

What the payments were for

  • Food & beverage$376100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie13$243
CSL Behring3$48
Gilead1$27
Octapharma USA, Inc.1$24
AstraZeneca1$20
Novartis1$14

How this compares

$376 in reported general payments places this provider in the 90th percentile of 2,431 emergency medicine providers in Ohio.

See all emergency medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$64,159
Medicare patients
499
Services billed
902

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl15$314

Paid to pharmacies, not to this prescriber.

Other emergency medicine in Marietta

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →